| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 18a | 0.520 | 0.846 |
|
group | 0.200 | None | 1.000 | 5 | 0 | 2009 | 2019 | |||||||||
|
microRNA 106b | 0.523 | 0.808 |
|
group | 0.200 | None | 1.000 | 4 | 0 | 2015 | 2019 | |||||||||
|
microRNA 25 | 0.517 | 0.769 |
|
group | 0.200 | None | 1.000 | 4 | 0 | 2010 | 2019 | |||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.690 | None | 0.929 | 3 | 0 | 1997 | 2019 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
group | 0.520 | None | 1.000 | 3 | 0 | 2000 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1985 | 2019 | ||||||||
|
glycine N-methyltransferase | 0.626 | 0.462 | 2.8E-03 |
|
group | 0.550 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
group | 0.270 | None | 1.000 | 2 | 0 | 1989 | 2018 | ||||||||
|
minichromosome maintenance complex component 7 | 0.572 | 0.654 | 1.9E-24 |
|
group | 0.220 | None | 1.000 | 2 | 0 | 2011 | 2016 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
group | 0.220 | None | 1.000 | 2 | 0 | 1987 | 2018 | ||||||||
|
microRNA 93 | 0.507 | 0.808 |
|
group | 0.210 | None | 1.000 | 2 | 0 | 2016 | 2019 | |||||||||
|
ATP binding cassette subfamily B member 4 | 0.529 | 0.615 | 2.2E-07 |
|
group | 0.210 | None | 1.000 | 2 | 0 | 1993 | 2017 | ||||||||
|
thioredoxin interacting protein | 0.490 | 0.731 | 0.16 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 1998 | 2006 | ||||||||
|
microRNA 96 | 0.536 | 0.769 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.945 | 1 | 0 | 1991 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.660 | None | 1.000 | 1 | 0 | 1993 | 2017 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
group | 0.580 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.550 | None | 1.000 | 1 | 0 | 2006 | 2016 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
group | 0.540 | None | 1.000 | 1 | 0 | 1990 | 2016 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
group | 0.530 | None | 1.000 | 1 | 0 | 1995 | 2001 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2009 | ||||||||
|
asparagine synthetase (glutamine-hydrolyzing) | 0.595 | 0.692 | 9.4E-06 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 1976 | 2017 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
group | 0.380 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
group | 0.300 | None | 0.909 | 1 | 0 | 1992 | 2018 |